Clinical Trial Update: Gemcitabine With or Without Cisplatin in Treating Patients With Unresectable Locally Advanced or Metastatic Cholangiocarcinoma or Other Biliary Tract Tumors [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating gemcitabine with or without cisplatin in unresectable biliary tract cancers (cholangiocarcinoma, extrahepatic bile duct cancer, and g…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Cholangiocarcinoma
• Extrahepatic Bile Duct Cancer
• Gallbladder Cancer

Drugs mentioned

• CISPLATIN (cisplatin)
• Gemzar (gemcitabine)

Snippet

Sponsor: University College, London | Conditions: Extrahepatic Bile Duct Cancer, Gallbladder Cancer | Phase 3 | Status: COMPLETED